Rituximab-Associated Flare of Cryoglobulinemic Vasculitis

BACKGROUND: Patients with cryoglobulinemic vasculitis (CV) can develop disease flare after rituximab administration. The objective of our study was to describe the prevalence, clinical characteristics, predisposing factors, and outcomes of patients with rituximab-associated flare of CV. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Sy-Go, Janina Paula T., Thongprayoon, Charat, Herrera Hernandez, Loren P., Zoghby, Ziad, Leung, Nelson, Manohar, Sandhya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589694/
https://www.ncbi.nlm.nih.gov/pubmed/34805636
http://dx.doi.org/10.1016/j.ekir.2021.08.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589694/
https://www.ncbi.nlm.nih.gov/pubmed/34805636
http://dx.doi.org/10.1016/j.ekir.2021.08.024

Ejemplares similares